The finding that the renin-angiotensin system regulates pulmonary arterial smooth muscle cell migration may prove beneficial in the development of novel therapies for CTEPH (Zhang et al., 2018). This evidence concerns the gene REN and chronic thromboembolic pulmonary hypertension.